|Year : 2021 | Volume
| Issue : 1 | Page : 142
Prevalence and prevention of rheumatologic manifestations and their relationship with blood glucose control in patients with type ii diabetes
Zahra Kamiab1, Negar Shafaee2, Poya Saied Askar3, Mitra Abbasifard4
1 Department of Family Medicine, School of Medicine, Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2 General Physician, Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3 Medical Student, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4 Department of Internal Medicine, School of Medicine; Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
|Date of Submission||07-Oct-2019|
|Date of Acceptance||18-May-2020|
|Date of Web Publication||26-Oct-2021|
Department of Internal Medicine, Ali-Ibn Abi Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan
Source of Support: None, Conflict of Interest: None
Background: Musculoskeletal disorders in diabetic patients are associated with pain and disability, and thus, a significant reduction in quality of life. The current study was conducted with the aim of evaluating the frequency and prevention of rheumatologic manifestations and their association with blood glucose levels in diabetic patients. Methods: In this cross-sectional study, a total of 273 patients with type II diabetes, referred to the diabetes clinic, were selected by using the census method. Using a checklist, demographic, and clinical data, including duration of diabetes, blood glucose level, HbA1c, type of diabetes, BMI, history of smoking, blood pressure, serum cholesterol level, triglyceride, HDL, LDL, and musculoskeletal disorder type were analyzed using SPSS20 software application using independent t-test. Modeling was performed to obtain the best fit using logistic regression. The significance level was considered less than 0.05. Results: 62.6% of patients had at least one of the rheumatologic complications. The most common complication was related to carpal tunnel syndrome (26.4%), followed by muscle contraction (23.8%). By moderating the effects of other variables, the odds ratio for rheumatoid complications was obtained as 1.74 with one unit of increase in HbA1c, which was statistically significant. In examining the influential variables, high age, gender, smoking, and BMI showed statistically significant effects (). Conclusions: Given the high prevalence of musculoskeletal disorders in diabetic patients, early diagnosis and timely treatment of the complications are crucial. It is recommended that musculoskeletal examinations be included as an important part of regular care for these patients.
Keywords: Glycemic control, HbA1c, musculoskeletal disorder, Rafsanjan, type II diabetes
|How to cite this article:|
Kamiab Z, Shafaee N, Askar PS, Abbasifard M. Prevalence and prevention of rheumatologic manifestations and their relationship with blood glucose control in patients with type ii diabetes. Int J Prev Med 2021;12:142
|How to cite this URL:|
Kamiab Z, Shafaee N, Askar PS, Abbasifard M. Prevalence and prevention of rheumatologic manifestations and their relationship with blood glucose control in patients with type ii diabetes. Int J Prev Med [serial online] 2021 [cited 2021 Dec 5];12:142. Available from: https://www.ijpvmjournal.net/text.asp?2021/12/1/142/329347
| Introduction|| |
There is no doubt that diabetes is one of the most challenging health problems in the 21st century. In 2013, approximately 382 million cases of diabetes were reported around the world, which is estimated to increase to about 592 million by 2035. In Iran, based on the national reports, the prevalence of the disease was reported as 11.5% (about 4.5 million adult people) in 2011, which shows a growth of 35% compared to 2005; and it is estimated that the number of diabetic patients will reach 9.2 million by the year 2030. This significant growth of the disease will result in an increase in mortality and a decline in quality of life, as well as significant direct and indirect costs imposed on the health care system of the country.
Diabetes is associated with the development of microvascular and macrovascular complications, along with impairment in the function of other organs. One of the most well-known of these complications involves musculoskeletal disorders., Although musculoskeletal disorders do not lead to mortality, they are associated with pain and disability and a significant decline in quality of life. In addition, these are among the forgotten complications of diabetes, and patients and health care staff do not pay enough attention to them. The results of various studies have reported different frequencies for the occurrence of such complications. However, the most common musculoskeletal disorders in these patients include shoulder capsulitis, limited joint mobility, Dupuytren's contracture, carpal tunnel syndrome, and trigger finger. Other disorders are less commonly seen, and some disorders, such as myonecrosis, are seen merely in diabetic patients. Among naturally occurring reducing sugars, glucose exhibits the slowest glycation rate, unlike fructose, glucose-6-phosphate or glyceraldehyde-3-phosphate, which are intracellularly present at small levels but can form AGEs at a faster rate, especially under high temperatures, i.e., ex vivo. Recent studies have suggested that advanced glycation end-products (AGEs) may be a key factor in the development of metabolic memory in diabetic complications, because AGEs are produced and accumulated irreversibly in the body, depending on the degree of blood sugar regulation and duration.
Due to disability and reducing the function of diabetic patients These manifestations are of great importance. According to the costs associated with reducing and destroying patient performance on the community, investigating these rheumatologic manifestations is important. The importance of accurately estimating the prevalence of these disorders and the risk factors associated with them is clear in prevention, early diagnosis, and control of pain and disability caused by them. The objective of this study was to evaluate the prevalence and prevention of rheumatologic manifestations and their association with blood glucose levels in diabetic patients. Moreover, the study aimed to investigate some relevant risk factors in patients visiting a diabetes clinic in an educational hospital.
| Methods|| |
In this cross-sectional study, all patients referred to the diabetes clinic of an educational hospital were evaluated in the second half of 2016 based on the study's inclusion and exclusion criteria. The inclusion criteria included having diabetes, and a lack of rheumatoid autoimmune diseases, vascular collagen diseases, chronic kidney disease, and stroke, and lack of musculoskeletal disorders caused by ulcer or injury, which were determined based on clinical examination by a rheumatology specialist using laboratory tests, if necessary. These patients were diagnosed based on the American Diabetes Association criteria. The inclusion criterion included fasting blood glucose equal to or greater than 126 mg/dL in two measurements. The exclusion criteria included a lack of cooperation from patients for any reason and migration from the area of the study. A total of 273 people were selected using the census method. After obtaining a code from the Ethics Committee (IR.RUMS.REC.1395.88), a written informed consent form was obtained from diabetic patients before entering the study. A checklist was used to collect the data.
The checklist included two sections. The first section included demographic data (level of education, race, and living place), and the second section included clinical data (duration of diabetes in a month, blood glucose, HbA1c, type of diabetes, BMI, history of smoking, blood pressure, serum level of cholesterol, triglyceride, HDL, LDL, and the type of musculoskeletal disorder found in the patient). types of musculoskeletal disorder included adhesive capsulitis, carpal tunnel syndrome, shoulder-hand syndrome, neuropathic arthritis, Golfer's elbow, arthriticular neuropathy. All of the musculoskeletal diseases are diagnosed by a rheumatologic specialist Some of them by history and physical examination (clinical manifestations) for example trigger finger and adhesive capsulitis but some of them are diagnosed by clinical manifestation and paraclinical finding such as nerve condition velocity (NCV) (carpal tunnel syndrome). Some parts of the data were collected from the patient's medical records, and the information on the type of musculoskeletal disorder was obtained through clinical examination by a rheumatologic specialist. BMI in these patients was calculated by measuring the height and weight of the patients based on the conventional formula. Laboratory data and the data on the complete physical evaluation of each patient's organs were collected from the checklist of the patient and stored in specific folders on the computer.
Data analysis and statistical methods
The obtained data were entered into SPSS 20 software applications. Descriptive statistics (frequency, mean, and standard deviation) were used to achieve the objectives of the study. Kolmogorov-Smirnov test was also used to examine the distribution of the obtained data. An independent t-test was also utilized. Modeling was performed to obtain the best fit using logistic regression. The significance level was considered less than 0.05.
| Results|| |
In the present study, a total of 273 patients diagnosed with type II diabetes were investigated. In this study, 52.4% (n = 143) of the participants were male and 47.6% (n = 130) were female. The number of smokers among the participants in the study was 83 (30.4%). The demographic data and the underlying variables for the participants are presented in [Table 1].
|Table 1: Frequency distribution of underlying variables (qualitative variables) related to research samples|
Click here to view
[Figure 1] shows the frequency of the types of rheumatologic manifestations in diabetic patients. The incidence of at least one of the rheumatologic complications was 62.6%. The highest frequency was seen for carpal tunnel syndrome (72 patients or 26.4%), while the lowest frequency was seen for arthriticular neuropathy (7 patients or 2.6%) and hand-shoulder pain (7 patients or 2.6%).
[Table 2] also shows the frequency of age variables, duration of diabetes, serum level of fasting blood glucose, and HbA1c level during examination (quantitative variables).
|Figure 1: Frequency distribution of types of rheumatologic manifestations in terms of prevalence in research subjects|
Click here to view
|Table 2: Frequency distribution of underlying variables (quantitative variables) related to research subjects|
Click here to view
An independent t-test was used to examine the distribution of quantitative variables (FBS, HbA1c) in various rheumatologic manifestations [Table 3].
|Table 3: Distribution of variable FBS and HBA1C based on the types of rheumatologic manifestations in research subjects|
Click here to view
In the patients, the rheumatologic manifestations of adhesive capsulitis, carpal tunnel syndrome, shoulder-hand syndrome, neuropathic arthritis, Golfer's elbow, and the mean level of FBS were significantly higher than those in people without these manifestations (P<0.05).
To evaluate the risk factors for rheumatologic manifestations, logistic regression model was used, and the relationships between the variables associated with these complications were examined. The individuals with any of the rheumatologic complications were included in the affected group, and individuals without any of these complications were included in the non- affected group. Among different regression models, by adding the effective variables for rheumatologic complications (age, gender, smoking, BMI, HDL, LDL, Chol, TG, systolic blood pressure, FBS, HBA1C, and duration of diabetes), the model with the variables of age, gender, smoking, HBA1C, and BMI was the best model from a statistical point of view [Table 4]. The results can be interpreted as follows:
|Table 4: Descriptive characteristics of regression of variables affecting rheumatologic complications in patients studied|
Click here to view
With regards to the age variable, the likelihood of rheumatologic complications in people aged 60–80 years was 14.2 times higher than that for people with 60 years of age (baseline group), while it was 19.2 times higher in people aged 80 years and higher compared to people aged less than 60 years (P=0.001). With regard to gender, the likelihood of rheumatologic complications in female patients was 30.47 times higher than that of male patients. And with regards to the smoking variable, the likelihood of rheumatologic complications in smokers was 6.98 times higher than that of non-smokers (P=0.001). With regards to the BMI, the likelihood of rheumatologic complications in the patients with BMI of 18.5-25 was 28.91 times higher than that of the patients in the baseline group with BMI less than 18.5, which was statistically significant (P=0.001). The patients with BMI of 25-30 had a rheumatologic complication rate of 1.16 times more than that of the baseline group (value = 0.83). For patients with BMI>30, compared to the baseline group, these complications were 11.67 times more likely, which was statistically significant (P=0.009). With regards to HbA1c, by moderating the effects of other variables, for one unit of increase in the rate of HbA1c, the likelihood of rheumatoid complications was 1.74, which was statistically significant (P=0.01).
| Discussion|| |
Based on the results of this study, 62.6% of diabetic patients suffered from at least one of the rheumatologic complications. The most common complication was carpal tunnel syndrome (26.4%). The mean FBS level in the patients with adhesive capsulitis, carpal tunnel syndrome, shoulder-hand syndrome, neuropathic arthritis, and Golfer's elbow was significantly higher than that of people who did not have these manifestations. Moreover, the mean HBA1C level in the patients with adhesive capsulitis, diabetic cheiroarthropathy, hand-shoulder syndrome, neuropathic arthritis, and tennis elbow was significantly higher than that of people without these manifestations (P<0.05). With regards to the HbA1c variable, after moderating the effects of other variables, for one unit of increase in the rate of HbA1c, the likelihood of rheumatoid complications became 1.74, which was statistically significant. The variables of age, gender, smoking, and BMI had a statistically significant effect on the baseline group. Various studies have reported different rates for musculoskeletal disorders. For instance, its rate has been reported by about 50% in the study conducted by Egede, and 48.4% in the study conducted by Zabihi et al. Fatemi et al. evaluated the prevalence of musculoskeletal disorders in diabetic and prediabetic patients, and compared the results between the two groups. In this study, 83% of diabetic patients and 53% of pre-diabetic subjects had at least one musculoskeletal disorder. The important point in these studies is that although the rate of occurrence is significant in all these studies, the statistical differences might be due to the diversity of the disorders studied; for example, osteoarthritis, which has not been considered in the present study, as well as the differences in demographic characteristics, such as the patient's age range, lifestyle, and living place. The most common complication in this study was carpal tunnel syndrome (26.4%). In the study conducted by Fatemi et al., the prevalence rate of carpal tunnel syndrome in diabetic and pre-diabetic people was estimated to be 48% and 36%, respectively. In the study conducted by Clarke et al., some complications, such as carpal tunnel syndrome and hand joints limitations, were more common due to higher transfer and richer sedimentation of sugar metabolites in hand tissues, which have more mobility.
However, in contrast to our study, Cagliero et al. reported that the most common musculoskeletal complication was shoulder capsulitis (52.5%), followed by carpal tunnel syndrome. Linsay et al. also reported that the most common musculoskeletal complication in the diabetic patients was shoulder capsulitis (53.8%), possibly because of sedimentation of glucose metabolites in capsule and cartilage tissues. The higher incidence of carpal tunnel syndrome might be related to neuropathy caused by diabetes, emerging with symptoms similar to carpal tunnel, thus, electromyography (EMG)-NCV is needed to differentiate them. Various studies have been carried out in order to evaluate the relationship between the underlying risk factors and musculoskeletal disorders in diabetic patients. For example, in the study conducted by Kyani et al., factors, including age, being female, smoking, and the duration of diabetes were associated with various types of musculoskeletal disorders. Similar to our study, Fatemi showed that age, gender, and BMI were important indicators for the development of musculoskeletal disorders in all diabetic and pre-diabetic people. Moreover, Fatemi suggested that age and BMI were two factors with a significant association with musculoskeletal disorders in both diabetic and prediabetic people. In addition, in the study conducted by Akulovar et al., and other similar studies,, a significant relationship was found between the occurrence of carpal tunnel syndrome and being female, which is consistent with results of our study, which contrasts with the results of some other studies.
With regard to the relationship between glucose control and rheumatologic complications, controversial results have been reported by different studies. In the present study, a significant relationship was found between the level of HbA1c, as an indicator of glucose control, and the occurrence of rheumatologic complications. The study conducted by Shakibi et al. showed that with better control of blood glucose, the incidence of these disorders decreases. In the study of Indian researchers, age, duration of diabetes, and glycosylated hemoglobin showed a significant relationship with these disorders. Their relationship with age and blood glucose control was consistent with the results of our study, but their relationship with the duration of diabetes contradicts the results of our study. It should be noted that this study also examined knee osteoarthritis. Moreover, in the study conducted by Sinagh et al. on patients with type I diabetes, no significant relationship was found between carpal tunnel syndrome and glucose control. Other studies have found that there is no significant relationship between serum HbA1c levels and rheumatologic manifestations. Considering a prevalence rate of over 50% for these musculoskeletal complications in many of the studies, it seems that screening for musculoskeletal complications should be included as an essential part of care for patients with type II diabetes. Diabetic patients and related physicians need to be trained on and pay more attention to these debilitating diabetic complications since early diagnosis and timely treatment of these complications can prevent chronic disabilities. The important point is that better control of diabetes can lead to reduced rheumatologic complications.
| Conclusions|| |
Diabetes often affects the musculoskeletal system and its complications have an adverse impact on patients' quality of life and mortality. Hence, diagnosis, prevention, and treatment of these complications are very crucial. It is recommended that musculoskeletal examinations be included as an important part of regular care for these patients. It is also recommended that studies with a higher sample size be conducted by considering other factors, such as job and the effect of geographical factors and living place.
Limitations and recommendations
The type of research and the limitations of the research population limit the range of generalization of the results and interpretations of the variables of the study. Therefore, it is recommended to other researchers interested in rheumatology and its relationship with diabetes to examine the accuracy of these results in a wider population along with a control group.
The authors would like to thank the clinical research development center for its support and collaboration in Ali-Ibn Abi Talib Hospital, Rafsanjan University of Medical Sciences.
All Authors reviewed the article and they have agreed with the contents of the paper.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al
. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract 2014;103:319-27.
Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: Evidence from micro-simulation Markov model and Bayesian meta-analysis. PLoS One 2015;10:e0132505.
Ceriello A. Postprandial hyperglycemia and diabetes complications: Is it time to treat? Diabetes 2005;54:1-7.
Mueller MJ. Musculoskeletal impairments are often unrecognized and underappreciated complications from diabetes. Phys Ther 2016;96:1861-4.
Molsted S, Tribler J, Snorgaard O. Musculoskeletal pain in patients with type 2 diabetes. Diabetes Res Clin Pract 2012;96:135-40.
Merashli M, Chowdhury TA, Jawad ASM. Musculoskeletal manifestations of diabetes mellitus. QJM 2015;108:853-7.
Singla R, Gupta Y, Kalra S. Musculoskeletal effects of diabetes mellitus. J Pak Med Assoc 2015;65:1024-7.
Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: Cause, effect, or both? Curr Diabetes Rep 2014;14:453.
Rhee SY, Kim YS. The role of advanced glycation end products in diabetic vascular complications. Diabetes Metab J 2018;42:188-95.
Gharre S, Hashemzadeh K, Masoom A. Frequency and pattern of upper limb musculoskeletal disorders in type 2-diabetes mellitus patients. J Med Sci 2012;2:1-11.
Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004;27:421-8.
Zabihiyeganeh M, Ghorbanpoor S, Jahed SA, Golgiri F. Frequency of upper limb musculoskeletal manifestations in 188 type 2 diabetic patients, referring to diabetes clinic of firouzgar hospital, 2011. JBUMS 2014;16:99-105.
Fatemi A, Iraj B, Barzanian J, Maracy M, Smiley A. Musculoskeletal manifestations in diabetic versus prediabetic patients. Int J Rheum Dis 2015;18:791-9.
Clarke CF, Piesowicz AT, Spathis GS. Limited joint mobility in children and adolescents with insulin dependent diabetes mellitus. Ann Rheum Dis 1990;49:236-7.
Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112:487-90.
Lindsay JR, Kennedy L, Atkinson AB, Bell PM, Carson DJ, McCance DR, et al
. Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year period. Diabetes Care 2005;28:658-61.
Kiani J, Goharifar H, Moghimbeigi A, Azizkhani H. Prevalence and risk factors of five most common upper extremity disorders in diabetics. J Res Health Sci 2013;14:93-6.
Akulwar AS, Ghugare BW, Singh R, Kanchankar N, Joshi M, Ramavat M. Clinical and electrophysiological evaluation of carpel tunnel syndrome in diabetes mellitus to assess association of age, gender and duration of diabetes on median neuropathy at wrist. Health Agenda 2013;1:71-6.
Lam N, Thurston A. Association of obesity, gender, age and occupation with carpal tunnel syndrome. Aust N Z J Surg 1998;68:190-3.
Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, et al
. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 2002;113:1429-34.
Gamstedt A, Holm-Glad J, Ohlson CG, Sundstrom M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med 1993;234:189-93.
Shakibi MR, Atapour J, Kalantari B, Namjoo B. Evaluation of frequency and risk factors of soft tissue rheumatism of upper limbs in diabetic patients in Kerman in 2001. Avicenna J Clin Med 2003;10:20-6.
Mathew AJ, Nair JB, Pillai SS. Rheumatic-musculoskeletal manifestations in type 2 diabetes mellitus patients in south India. Int J Rheum Dis 2011;14:55-60.
Singh R, Gamble G, Cundy T. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes. Diabet Med 2005;22:625-30.
Attar SM. Musculoskeletal manifestations in diabetic patients at a tertiary center. Libyan J Med. 2012;7:1.
[Table 1], [Table 2], [Table 3], [Table 4]